Leda Mannent

Leda Mannent is currently the Global Project Head for Immunology and Inflammation at Sanofi, overseeing the late-stage development of a small molecule for multiple autoimmune and Type 2 inflammatory conditions. In previous roles at Sanofi Genzyme, Mannent served as Senior Director of Clinical Research, leading the global clinical development of Dupixent across various indications. Prior to that, they held positions at sanofi-aventis as a Senior Clinical Research Director and Global Safety Officer. Leda's early career included significant contributions in pediatric hematology and oncology at institutions like the Assistance Publique – Hôpitaux de Marseille and the Children Hospital of Tirana. They hold a Doctor of Medicine degree from the University of Tirana and a Master’s in Biological and Medical Sciences from Université Montpellier 1.